The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

23 articles for L Lai


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of acylthiourea derivatives as potent Plk1 PBD inhibitors.EBI
Peking University
Discovery of Novel 15-Lipoxygenase Activators To Shift the Human Arachidonic Acid Metabolic Network toward Inflammation Resolution.EBI
University of California San Diego
Discovery of highly potent TNFa inhibitors using virtual screen.EBI
Peking University
Benzo[d]isothiazole 1,1-dioxide derivatives as dual functional inhibitors of 5-lipoxygenase and microsomal prostaglandin E(2) synthase-1.EBI
Peking University
Development of 3,5-dinitrobenzoate-based 5-lipoxygenase inhibitors.EBI
Peking University
Discovery of highly potent microsomal prostaglandin e2 synthase 1 inhibitors using the active conformation structural model and virtual screen.EBI
Peking University
Optimization of 5-hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase.EBI
Peking University
Dynamic modeling of human 5-lipoxygenase-inhibitor interactions helps to discover novel inhibitors.EBI
Peking University
Quinoline-4-methyl esters as human nonpancreatic secretory phospholipase A2 inhibitors.EBI
Peking University
Discovery of dual target inhibitors against cyclooxygenases and leukotriene A4 hydrolyase.EBI
Peking University
Discovering potent small molecule inhibitors of cyclophilin A using de novo drug design approach.EBI
East China University of Science and Technology
Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching.EBI
Peking University
Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives.EBI
Peking University
Discovery of 3-oxo-1,2,3,4-tetrahydropyrido[1,2-a]pyrazin derivatives as SARS-CoV-2 main protease inhibitors through virtual screening and biological evaluation.EBI
Peking University
Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors.EBI
Peking University
Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main protease.EBI
Peking University
Quinoline-4-acetamides as sPLA(2) inhibitors.EBI
Peking University
Discovery of Novel Polo-Like Kinase 1 Polo-Box Domain Inhibitors to Induce Mitotic Arrest in Tumor Cells.EBI
Peking University
Multidrug resistance protein 4 (MRP4/ABCC4) mediates efflux of bimane-glutathione.EBI
National University of Singapore
Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereofBDB
Pharmaxis
Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors.BDB
University of Bari